Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NENT Group proposes rebrand to Viaplay Group

· Proposal reflects company’s strategic focus on Viaplay and its international expansion and Nordic growth · Viaplay is NENT Group’s most recognisable brand and the only one present in all its markets, and the company’s largest single revenue-generating unit · Rebrand subject to shareholder approval at AGM on 18 May Nordic Entertainment Group (NENT Group) will propose a rebrand of the company to Viaplay Group. The proposal reflects NENT Group’s strategic focus on the Viaplay streaming service and its ongoing international expansion and continued Nordic growth. Viaplay is NENT Group’

NCC to sell logistics project in Gothenburg to Barings

NCC is divesting the Albatross logistics project in Arendal to Barings for an agreed property value of approximately SEK 530 million. Photo of Arendal from above: NCC Albatross is the fifth and final stage of Arendal Green Park at the Port of Gothenburg, where NCC is developing an approximately 34,000-square-meter logistics building. “Arendal is in a prime location, which will be strategically important to us due to its close proximity to both the largest port in the Nordics and local highway network. We are delighted to be able to again cooperate with NCC, this time in the

HoloMonitor Fluorescence Now at Novo Nordisk

Phase Holographic Imaging (PHI) recently installed a fluorescence-equipped HoloMonitor® system at Novo Nordisk A/S. The installation is part of a series of test installations to allow experienced HoloMonitor customers to provide feedback regarding functionality and user-friendliness prior to the upcoming product launch.Fluorescence microscopy is an essential tool used by cell biologists to study the genetic activity of cells. However, fluorescence microscopy is harmful to the cells, making it difficult to study genetic activity over time. PHI solves this dilemma by combining holography with

Sanctions against Russian exports will permanently alter the global trade of forest products

Lumber trade flows changed almost instantly when Russia invaded Ukraine in late February. Trade sanctions and restrictions in financial transactions by Europe, North America, and major markets in Asia halted shipments from Russia and Belarus. In addition, exports from Ukraine were also disrupted. The total lumber exports from the three countries in the war zone were 34 million m[3] in 2021. Over 25% of that volume was exported to countries with current sanctions against Russia and Belarus. In addition, the two major wood certification organisations, FSC and PEFC, have labeled all timber

Q-Free: Mandatory notification of trade

(Oslo 29 March 2022) Håkon Volldal, President & CEO of Q-Free ASA, has today bought 18,293 shares in Q-Free ASA at an average price of NOK 7.50 per share. The shares were acquired through Bright Future AS, a company controlled by Volldal. Following this transaction Volldal controls 243,293 shares in Q-Free ASA. The notification form is included in the attachment. This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Josemaria Announces the Mailing of Meeting Materials in Connection with the Special Meeting to Approve Acquisition by Lundin Mining

VANCOUVER, BC, March 29, 2022 /CNW/: Josemaria Resources Inc. (TSX: JOSE) (OMX: JOSE) (OTCQB: JOSMF) (“Josemaria” or the “Company”), is pleased to announce it has mailed and filed a management information circular dated March 16, 2022 (the “Circular”) and related meeting materials (collectively, the “Meeting Materials”) for its special meeting (the “Meeting”) of Securityholders (as defined below) to be held April 21, 2022, in connection with the proposed acquisition of all of the outstanding shares of the Company (“Josemaria Shares”) by Lundin Mining Corporation (“Lundin Mining”) (TSX:LUN) (

All conditions for BillerudKorsnäs’ acquisition of Verso have been fulfilled

All regulatory approvals required for BillerudKorsnäs’ acquisition of Verso, which has been communicated previously, have now been obtained. Therefore, BillerudKorsnäs and Verso agreed today that all conditions for completion of the transaction have been fulfilled. The transaction is expected to be completed on 31 March 2022. Verso will be consolidated into the accounts of BillerudKorsnäs as of that date.For more information, please contact:Ivar Vatne, CFO, +46 8 553 335 07Lena Schattauer, Head of Investor Relations, +46 8 553 335 10 This information was submitted for publication,

MapsPeople Annual Report 2021

MAY NOT BE PUBLISHED, DISTRIBUTED, OR SUPPLIED OR IN PARTICULAR, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, AUSTRALIA, CANADA, OR JAPAN. Company Announcement No. 4 - 2022 Aalborg, March 29[th] 2022 Annual Report for the period January 1, 2021 to December 31, 2021 This message contains inside information MapsPeople reports an Annual Recurring Revenue (ARR) growth of 50% corresponding to mDKK 41.1 which is in line with the latest ARR guidance. (Company Announcement no. 13-2021). Highlights in 2021 · Total ARR increased by 50% to mDKK 41.1 · MapsIndoors ARR increased

Correction: SelectImmune Pharma AB to conduct clinical trials in cystitis and bladder pain syndrome

As of March 29[th], SelectImmune Pharma AB has signed an agreement with Swedish Orphan Biovitrum (Sobi®) to buy Kineret® (anakinra) and placebo in order to investigate anakinra as a potential treatment of patients with select forms of cystitis and bladder pain syndrome.Extensive research into the molecular mechanism of cystitis at Lund University has identified interleukin-1 alpha and beta as a major regulator of inflammation and disease in acute cystitis and bladder pain syndrome. The interleukin-1 alpha and beta receptor antagonist (IL1-RA) anakinra has been shown to inhibit inflammation

Gram Car Carriers executes vessel swap and signs five-year TC contract for Viking Emerald

Oslo, 29 March 2022: Gram Car Carriers ASA (“GCC”) is pleased to announce that the company has signed a five-year time charter contract for the MV Viking Emerald (4,200 CEU) with a leading Asian operator. The contract commences in May 2022 at a time charter rate of USD 28,000 per day, providing a total contract value of approximately USD 51 million over the five-year period.  Viking Emerald was originally contracted to another major Asian operator on a two-year time charter from May 2022. GCC has agreed to swap the Viking Emerald with the Viking Coral (4,200 CEU), which is coming off its

Nordea Bank Abp: Repurchase of own shares on 29.03.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares29.03.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 29.03.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XSTO 377,978 9.61 3,633,535.03XHEL 235,773 9.56 2,253,777.68CEUX 222,133 9.59 2,130,181.33AQEU 27,422 9.58 262,728.51

Notice of Annual General Meeting Samhällsbyggnadsbolaget i Norden AB (publ)

The shareholders of Samhällsbyggnadsbolaget i Norden AB (publ), corp. id. no 556981-7660, (the “Company”) are hereby given notice to attend the Annual General Meeting on Wednesday 27 April 2022, at 16:00. The Annual General Meeting will be held in Annexet, Globentorget, Entré 2 in Stockholm. Entrance and registration take place from 12:00. In addition to the formal Annual General Meeting, shareholders are invited to a light lunch with a subsequent seminar consisting of presentations and question time. More information is presented on the Company's website, www.sbbnorden.se. The Board

Ericsson’s Annual General Meeting 2022

Telefonaktiebolaget LM Ericsson’s (NASDAQ:ERIC) Annual General Meeting (AGM) was held on March 29, 2022. Due to COVID-19, the AGM 2022 was conducted without the physical presence of shareholders, representatives and third parties and the meeting was conducted as a digital meeting with online participation. Shareholders were also able to exercise their voting rights by post before the meeting. Adoption of the Profit and Loss Statements and the Balance Sheets The AGM resolved to adopt the Profit and Loss Statement and the Balance Sheet for the Parent Company as well as the Consolidated

Executive Team and Board of Directors reaffirm commitment to deliver strategy and continue compliance transformation journey

Ericsson (NASDAQ: ERIC) Executive Team and Board of Directors reaffirm commitment to deliver Ericsson strategy and continue compliance transformation journey. At Ericsson’s 2022 Annual General Meeting, it was recorded that shareholders representing at least one tenth of all of the shares in the Company voted against discharge from liability of the Board of Directors and the President for the financial year 2021 while also electing Board members in accordance with the Nomination Committee’s proposals, which including re-election of all prior Board members. Speaking after the general

#22-110 Adjustment to warrants with Skanska AB as underlying due to extraordinary dividend.

The recalculation will be effective from March 30, 2022. Please contact the issuer for detailed information about the recalculation.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace

Announcement from SyntheticMR's extra general meeting

The extra general meeting of SyntheticMR AB (publ) ("SyntheticMR" or the "Company") was held today on 29 March 2022 and the following resolutions were passed by the shareholders. Approval of the board's resolution of a directed share issue The extra general meeting unanimously resolved, in accordance with the board's proposal, to approve the board's resolution of a share issue of a maximum of 1,250,000 shares with deviation from the shareholders' preferential rights at a subscription price of SEK 48 per share. The reason for deviating from the shareholders' pre-emptive rights is to

FluoGuide A/S issue warrants to employees and management

Copenhagen, Denmark, 29 March 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that based on the approved Incentive program from 9 February 2021, FluoGuide is issuing 40,000 warrants to management, and employeesToday, the Board of Directors of FluoGuide has exercised its authorization to issue new warrants by issuing 40,000 warrants to employees and management. All warrants are issued free of change. Warrants are issued to ensure alignment of interests between the Company’s employees, management, and shareholders. The Company believes that the issue of warrants

Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders

Herantis Pharma Plc    Company release         29 March 2022 at 7:55 p.m. EEST Notice is given to the shareholders of Herantis Pharma Plc to the Annual General Meeting of the Company to be held on 21 April 2022, commencing at 10.00 a.m. (Eastern European Summer Time) at the premises of Krogerus Attorneys Ltd, at the address Fabianinkatu 9, 00130 Helsinki, Finland. Shareholders of the Company and their proxy representatives may participate and exercise their shareholder rights in the meeting only by voting in advance and by submitting counterproposals and asking questions in advance.

Herantis Pharma Plc is contemplating carrying out a directed share issue and a rights issue

Herantis Pharma PlcCompany release, inside information, 29 March 2022 at 7:45 p.m. EEST THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Herantis Pharma Plc ("Herantis" or the "Company"), an innovative biotech company developing new disease modifying therapies for Parkinson's disease, is contemplating two separate share issues with a preliminary

Answer the Call to Glory in Crusader Kings III for Console

Paradox’s award winning medieval strategy game now on latest Xbox and PlayStation modelsSTOCKHOLM - 29 March 2022 - New kingdoms are ready to be founded, and new dynasties will be honored worldwide as Crusader Kings III comes to to Xbox Series X|S and PlayStation 5 today. Paradox’s much loved grand strategy role-playing game has been thrilling PC gamers since 2020, and now players on other platforms have the chance to relive and rewrite medieval history. In Crusader Kings III, players lead a royal family through the centuries, controlling characters and their heirs as they try to

Statement by the independent bid committee of Svedbergs in relation to the mandatory public offer from Stena Adactum

Svedbergs i Dalstorp AB (publ) (”Svedbergs” or the “Company”) independent bid committee unanimously recommends the shareholders of Svedbergs to not accept the cash-based mandatory public offer submitted by Stena Adactum AB (“Stena Adactum”) on 22 March 2022. Background This statement is made by the independent bid committee of the Board of Directors of Svedbergs in accordance with Nasdaq Stockholm’s Takeover Rules (“Takeover Rules”). On 14 March 2022, Svedbergs’ largest shareholder Stena Adactum announced that Stena Adactum had acquired 354,700 B shares in Svedbergs for a maximum

ANNOUNCING REDUCED TRANSACTION COST IN RELATION TO IPO OFFER

On 24 March 2022, Katalysen Ventures AB (publ)’s investment memorandum was approved by Spotlight Stock Market. In this investment memorandum it is stated that IPO related transaction costs add up to approximately MSEK 1.9 (17.3% of the total issue amount). Today, Katalysen Ventures can announce that the transaction cost stated in the memorandum has been revised down to approximately MSEK 1.39 (12.6% of the total issue amount).

SRV Group Plc: Repurchase of own shares on 29 March 2022

SRV GROUP PLC     STOCK EXCHANGE RELEASE     29 MARCH 2022      18:45 EET   SRV Group Plc repurchase of own shares on 29.03.2022     +------------------------+----------+|SRV Group Plc |  |+------------------------+----------+|In the Nasdaq Helsinki |  |+------------------------+----------+|Date |29.03.2022|+------------------------+----------+|Exchange transaction |BUY |+------------------------+----------+|Share trading code |SRV1V |+------------------------+----------+|Amount, shares

There are no items matching the current filter
There are no more items matching the current filter
Back to top